| QuidelOrtho Corp |
Director |
Common Stock |
37,061 |
$1,030,688 |
$27.81 |
25 Nov 2025 |
Direct |
| QuidelOrtho Corp |
Director |
Restricted Stock Units (Converted) |
2,926 |
$83,720 |
$39.64 |
29 May 2025 |
Direct |
| QuidelOrtho Corp |
Director |
Restricted Stock Units (Premium) |
878 |
$25,092 |
$39.64 |
29 May 2025 |
Direct |
| QuidelOrtho Corp |
Director |
Restricted Stock Units (Equity Grant) |
6,829 |
$0 |
$39.64 |
29 May 2025 |
Direct |
| Personalis, Inc. |
Director |
Stock Option (right to buy) |
50,000 |
|
|
16 May 2025 |
Direct |
| Evoke Pharma Inc |
Director |
Stock Option (Right to Buy) |
0 |
|
|
17 Dec 2025 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Common Stock |
0 |
|
$15.73 |
27 May 2022 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Non-Qualified Stock Options |
0 |
|
|
27 May 2022 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Restricted Stock Units |
0 |
|
|
27 May 2022 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Restricted Stock Units (Converted) |
0 |
|
|
15 May 2022 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Restricted Stock Units (Equity Grant) |
0 |
|
|
18 May 2022 |
Direct |
| QUIDEL CORP /DE/ |
Director |
Restricted Stock Units (Premium) |
0 |
|
|
15 May 2022 |
Direct |
| QuidelOrtho Corp |
Director |
Non-Qualified Stock Options |
0 |
|
|
25 Nov 2025 |
Direct |